When was Bioscript founded?

Bioscript was founded in 2011 and raised its 1st funding round 10 years after it was founded.

Where is Bioscript located?

Bioscript is headquartered in Macclesfield, United Kingdom. It is registered at ROPEWALKS,NEWTON ST,MACCLESFIELD,UNITED KINGDOM,SK11 6QJ.

How many employees does Bioscript have?

As of Jun 30, 2026, the latest employee count at Bioscript is 181.

Is Bioscript a funded company?

Bioscript is a funded company, having raised a total of $***** in its 1st and only funding round, a PE round on Mar 04, 2021.

When was the latest funding round of Bioscript?

Bioscript's latest funding was a $***** PE round on Mar 04, 2021, with participation from 1 investor.

Where does Bioscript rank among its competitors?

Bioscript ranks 73rd amongst 1349 active competitors, of which 26 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Prescient Healthcare Group, which secured $18.3K in Jun, 2024.

Who are the top competitors of Bioscript?

Bioscript's top competitors include Indegene, IntegriChain and Prescient Healthcare Group. Among them, Prescient Healthcare Group secured the most recent funding round in June, 2024.

Bioscript - 2026 Company Profile, Team, Funding & Competitors

Bioscript is a late stage company based in Macclesfield (United Kingdom), founded in 2011. It operates as a Provider of scientific communications and market access consulting. Bioscript has raised an undisclosed amount in funding from Sovereign Capital. The company has 1349 active competitors, including 26 funded and 148 that have exited. Its top competitors include companies like Indegene, IntegriChain and Prescient Healthcare Group.

Company Details

Provider of scientific communications and market access consulting. It offers services in medical affairs, market access, and regulatory writing. The firm helps clients navigate complex diseases by connecting the right science to the right stakeholder at the right time. This is achieved through deep domain expertise, technology-enabled insights, and a global understanding of healthcare. Services streamline scientific strategy and improve patient access to new treatments. The company leverages specialist networks' experience to guide better decisions across therapy areas. Capabilities include data insights, strategic planning, medical communications, market access consulting, and regulatory writing.

Website: bioscriptgroup.com
Social
Email ID: *****@bioscriptgroup.com
Phone Number: +44 **********
Registered Address: ROPEWALKS,NEWTON ST,MACCLESFIELD,UNITED KINGDOM,SK11 6QJ

Key Metrics

Founded Year

2011

Location

Macclesfield, United Kingdom

Stage

Late Stage

Latest Funding Round

PE, Mar 04, 2021, $*****

Investors

Sovereign Capital & 1 more

Ranked

73^rd among 1349 active competitors

Employee Count

181 as on Jun 30, 2026

Investment & Acquisitions

Meridian HealthComms & 1 more

Similar Companies

Indegene & 1608 more

View Bioscript's full profile

Bioscript is associated with 4 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
BIOSCRIPT STIRLING LIMITED CIN: 4354625 , United Kingdom, Active	Jan 16, 2002	£10M - £50M (As on Sep 30, 2023)	98 (As on Sep 30, 2024)
BIOSCRIPT GROUP LIMITED CIN: 9542360 , United Kingdom, Active	Apr 13, 2015	-	-
BIOSCRIPT SCIENCE, LLC CIN: 6884044 , United States, Active	Jun 21, 2023	-	-	-
BIOSCRIPT LIMITED CIN: 13216692 , United Kingdom, Active	Feb 21, 2021	£1M - £10M (As on Sep 30, 2024)	13 (As on Sep 30, 2024)

Bioscript has raised funding over 1 round. Its latest funding round was a PE round on Mar 04, 2021 for $*****. 1 investor participated in its latest round. Bioscript has 2 institutional investors.

Here is the list of recent funding rounds of Bioscript:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 04, 2021	7348431	PE	5426793	9352767	4839406	9377449

Access funding benchmarks and valuations. Sign up today!

View details of Bioscript's funding rounds and investors

Bioscript's employee count trend

Bioscript has 181 employees as of Jun 26. Here is Bioscript's employee count trend over the years:

Uncover Bioscript's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Bioscript include Indegene, IntegriChain and Prescient Healthcare Group. Here is the list of Top 10 competitors of Bioscript, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Indegene 1998, Princeton (United States), Public	Suite solutions for payers and healthcare providers	$255M	Syneos Health, Cadawninvestmentcompany & 17 others	78/100
2nd	IntegriChain 2005, Philadelphia (United States), Acquired	Pharma commercialization solutions: data, consulting, and technology for market access	$2M	Activate Venture Partners, SaaS Capital & 4 others	63/100
3rd	Prescient Healthcare Group 2007, London (United Kingdom), Series B	Consulting services for product strategy and decision support	$12.7M	Bridgepoint Group, Intertrust & 8 others	60/100
4th	Clinigen 2010, Burton-on-trent (United Kingdom), Acquired	Services in clinical trials & medicine supply	-	RBS Group, Santander Bank & 3 others	59/100
5th	CMIC HOLDINGS 1985, Tokyo (Japan), Acquired	Contract service provider for biopharma companies	-	-	58/100
6th	Fishawack 2001, Brighton (United Kingdom), Acquired	Provider of fully-integrated, cross-border services to global pharmaceutical organisations	$23.6M	-	57/100
7th	Fabtech 2002, Mumbai (India), Public	Provider of instruments for biotech, pharmaceutical, and biomedical industries	$175K	Acaciaa International TR LLC, T Square Enterprises ... & 9 others	56/100
8th	Diaceutics 2005, Belfast (United Kingdom), Public	Analytics based integrator for precision medicine	-	Herald Investment Management, SVB & 4 others	55/100
9th	Spectrum Pharmatech Consultants 1995, Thane (India), Unfunded	Provider of diversified consulting services for biopharma sector	-	-	49/100
10th	Avalon Bio Ventures 1983, San Diego (United States), Unfunded	Venture capital firm and startup accelerator focused on life science companies	-	-	48/100
73rd	Bioscript 2011, Macclesfield (United Kingdom), Late Stage	Provider of scientific communications and market access consulting	-	Kartesia, Sovereign Capital	35/100